Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies.

Arboix A, Blanco-Rojas L, Martí-Vilalta JL.

Expert Rev Neurother. 2014 Mar;14(3):261-76. doi: 10.1586/14737175.2014.884926. Epub 2014 Feb 4. Review.

PMID:
24490992
2.

Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).

Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ; International Citicoline Trial on acUte Stroke (ICTUS) trial investigators.

Lancet. 2012 Jul 28;380(9839):349-57. doi: 10.1016/S0140-6736(12)60813-7. Epub 2012 Jun 11.

PMID:
22691567
3.

Value of carotid intima-media thickness and significant carotid stenosis as markers of stroke recurrence.

Roquer J, Segura T, Serena J, Cuadrado-Godia E, Blanco M, García-García J, Castillo J; ARTICO Study.

Stroke. 2011 Nov;42(11):3099-104. doi: 10.1161/STROKEAHA.110.612010. Epub 2011 Aug 18.

4.

Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis.

Martinez-Ramirez S, Delgado-Mederos R, Marín R, Suárez-Calvet M, Sáinz MP, Alejaldre A, Vidal-Jordana Á, Martí-Vilalta JL, Martí-Fàbregas J.

J Neurol. 2012 Jan;259(1):111-8. doi: 10.1007/s00415-011-6137-3. Epub 2011 Jun 18.

PMID:
21688044
5.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.

Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25. Erratum in: Lancet. 2011 Jul 30;378(9789):402.

PMID:
21616527
6.

Diagnosis of CADASIL disease in normotensive and non-diabetics with lacunar infarct.

Cocho D, Martí-Fàbregas J, Baiget M, Gallardo E, Rio E, Arboix A, Ruscalleda J, Martí-Vilalta JL.

Neurologia. 2011 Jul-Aug;26(6):325-30. doi: 10.1016/j.nrl.2010.12.004. Epub 2011 Feb 22. English, Spanish.

7.

Hemostatic proteins and their association with hematoma growth in patients with acute intracerebral hemorrhage.

Martí-Fàbregas J, Borrell M, Silva Y, Delgado-Mederos R, Martínez-Ramírez S, de Juan-Delago M, Tirado I, Alejaldre A, Marín R, Martí-Vilalta JL, Fontcuberta J.

Stroke. 2010 Dec;41(12):2976-8. doi: 10.1161/STROKEAHA.110.595868.

8.

Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.

Martinez-Ramirez S, Delgado-Mederos R, Martí-Vilalta JL, Martí-Fàbregas J.

Neurology. 2010 Nov 16;75(20):1853; author reply 1854. doi: 10.1212/WNL.0b013e3181fac7da. No abstract available.

PMID:
21079190
9.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G.

Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6.

PMID:
20472172
10.

Remote cerebral hematomas in patients treated with intravenous rt-PA.

Martínez-Hernández E, Martínez-Ramírez S, Delgado-Mederos R, Alcolea D, Marquié M, Marín R, De Juan M, Martí-Vilalta JL, Martí-Fàbregas J.

J Neurol. 2010 Jul;257(7):1062-6. doi: 10.1007/s00415-010-5462-2. Epub 2010 Feb 6.

PMID:
20140445
11.

Proliferation in the human ipsilateral subventricular zone after ischemic stroke.

Martí-Fàbregas J, Romaguera-Ros M, Gómez-Pinedo U, Martínez-Ramírez S, Jiménez-Xarrié E, Marín R, Martí-Vilalta JL, García-Verdugo JM.

Neurology. 2010 Feb 2;74(5):357-65. doi: 10.1212/WNL.0b013e3181cbccec. Epub 2010 Jan 6.

PMID:
20054008
12.

Mutations in the NKX2-5 gene in patients with stroke and patent foramen ovale.

Belvís R, Tizzano EF, Martí-Fàbregas J, Leta RG, Baena M, Carreras F, Pons-Lladó G, Baiget M, Martí-Vilalta JL.

Clin Neurol Neurosurg. 2009 Sep;111(7):574-8. doi: 10.1016/j.clineuro.2009.04.004. Epub 2009 May 21. Erratum in: Clin Neurol Neurosurg. 2010 Feb;112(2):176.

PMID:
19464101
13.

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators.

Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16. Erratum in: .

PMID:
19372653
14.

Lacunar stroke.

Arboix A, Martí-Vilalta JL.

Expert Rev Neurother. 2009 Feb;9(2):179-96. doi: 10.1586/14737175.9.2.179. Review.

PMID:
19210194
15.

Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.

Serena J, Marti-Fàbregas J, Santamarina E, Rodríguez JJ, Perez-Ayuso MJ, Masjuan J, Segura T, Gállego J, Dávalos A; CODICIA, Right-to-Left Shunt in Cryptogenic Stroke Study; Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology.

Stroke. 2008 Dec;39(12):3131-6. doi: 10.1161/STROKEAHA.108.521427. Epub 2008 Sep 25.

16.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

17.

Blood pressure is not associated with haematoma enlargement in acute intracerebral haemorrhage.

Martí-Fàbregas J, Martínez-Ramírez S, Martínez-Corral M, Díaz-Manera J, Querol L, Suárez-Calvet M, de Juan M, Santaló M, Marín R, Martí-Vilalta JL.

Eur J Neurol. 2008 Oct;15(10):1085-90. doi: 10.1111/j.1468-1331.2008.02254.x. Epub 2008 Aug 20.

PMID:
18717722
18.

Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.

Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL.

Cerebrovasc Dis. 2008;26(2):126-33. doi: 10.1159/000139659. Epub 2008 Jun 17.

PMID:
18560215
19.

Re: The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial.

Martí-Fàbregas J, Martínez-Ramírez S, Martí-Vilalta JL.

Neurology. 2008 Apr 8;70(15):1296; author reply 1296-7. doi: 10.1212/01.wnl.0000312112.79733.ec. No abstract available.

PMID:
18391165
20.

Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.

Martí-Fàbregas J, Borrell M, Cocho D, Martínez-Ramírez S, Martínez-Corral M, Fontcuberta J, Martí-Vilalta JL.

Stroke. 2008 Jan;39(1):234-6. Epub 2007 Nov 29.

Supplemental Content

Loading ...
Support Center